Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04691505 · ClinicalTrials.gov registry record

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine

A clinical trial of Rheumatoid Arthritis, sponsored by Brigham and Women's Hospital.

Completed
Registry status
133,553
Enrollment target
1
Study location

NCT04691505 is a study of Rheumatoid Arthritis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 133,553 participants, above the 4,013-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (3228% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04691505, a study of Rheumatoid Arthritis, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
133,553 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Methotrexate
  • DRUG Hydroxychloroquine

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 133,553 participants
Start Date 2020-12-23
Est. Completion 2021-08-31

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04691505

The ClinicalTrials.gov registry entry for NCT04691505 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133,553 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,013-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (3228% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Methotrexate is the first listed.

NCT04691505 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04691505 about?

NCT04691505 is a clinical study titled "Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine". This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

What is the current status of trial NCT04691505?

This trial is currently completed. The enrollment target is 133,553 participants. The study started on 2020-12-23. Estimated completion is 2021-08-31.

What conditions does trial NCT04691505 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT04691505?

The interventions under investigation include: Methotrexate (DRUG), Hydroxychloroquine (DRUG).

Who is sponsoring clinical trial NCT04691505?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04691505 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.